Timothy J Pelura

Preclinical Research Leader Surpass CEO Dr. Timothy J Pelura, President and CEO, PhD, is a serial life science entrepreneur and accomplished executive with more than 35 years of experience in pharmaceutical, biotech and medical device industries and has been pivotal in the development of several new drugs spanning numerous therapeutic areas. He is a respected business leader with a long successful history of growing small companies within the life sciences space. In his most recent position he served as president of BioEntrep, a strategic consultancy focused on transforming life science technologies into high value, medical products by delivering sound advice and needed capacity in the areas of finance; business, corporate and preclinical development; clinical/regulatory strategy; and corporate communications. Prior to BioEntrep, he held positions as Chairman, President and CEO of Immunome, an antibody platform company; CEO of Promedior, a product-focused biotech company developing novel therapeutics for the treatment of fibrotic diseases; CSO of Kereos responsible for all R&D activities for their oncology, cardiology, and molecular imaging programs; President and COO of Provasis Therapeutics, a developer of interventional neurosurgical devices; as well as various other roles including executive R&D positions at Neuron Therapeutics, Alliance Pharmaceutical Corp., and Pharmacia. He earned his doctorate and master's degrees in Chemistry as well as a bachelor's degree in Biological Sciences from Rutgers University.